Advisory Services Network, LLC Iovance Biotherapeutics, Inc. Transaction History

Advisory Services Network, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$6.38 - $18.33 $40,991 - $117,770	-6,425 Closed	0 $0
Q1 2022 May 23, 2022	BUY	$12.38 - $19.1 $79,541 - $122,717	6,425 New	6,425 $107,000
Q4 2020 Feb 09, 2021	SELL	$28.04 - $50.26 $2,804 - $5,026	-100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $2,775 - $3,629	100 New	100 $3,000

303

221M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.27B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.